Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis
Studies have indicated inconsistent results regarding the association between plasma levels of Lipoprotein(a) [Lp(a)] and coronary artery calcification (CAC). We performed a systematic review and meta-analysis to investigate the association between elevated levels of Lp(a) and risk of CAC in populat...
Gespeichert in:
| Veröffentlicht in: | Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2023-11, Vol.33 (11), p.2055-2066 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2066 |
|---|---|
| container_issue | 11 |
| container_start_page | 2055 |
| container_title | Nutrition, metabolism, and cardiovascular diseases |
| container_volume | 33 |
| creator | Vazirian, Fatemeh Sadeghi, Masoumeh Kelesidis, Theodoros Budoff, Matthew J. Zandi, Zahra Samadi, Sara Mohammadpour, Amir Hooshang |
| description | Studies have indicated inconsistent results regarding the association between plasma levels of Lipoprotein(a) [Lp(a)] and coronary artery calcification (CAC). We performed a systematic review and meta-analysis to investigate the association between elevated levels of Lp(a) and risk of CAC in populations free of cardiovascular disease (CVD) symptoms.
PubMed, Web of Science, Embase, and Scopus were searched up to July 2022 and the methodological quality was assessed using Newcastle–Ottawa Scale (NOS) scale. Random-effects meta-analysis was used to estimate pooled odds ratio (OR) and 95% confidence interval. Out of 298 studies, data from 8 cross-sectional (n = 18,668) and 4 cohort (n = 15,355) studies were used in meta-analysis. Cohort studies demonstrated a positive significant association between Lp(a) and CAC, so that individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence compared to those with lower Lp(a) concentrations in asymptomatic CVD subjects (OR, 1.58; 95% CI, 1.38–1.80; l2, 0.0%; P, 0.483); Subgroup analysis showed that a cut-off level for Lp(a) measurement could not statistically affect the association, but race significantly affected the relationship between Lp(a) and CAC (OR,1.60; 95% CI, 1.41–1.81). Analyses also revealed that both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.
Blood Lp(a) level was significantly associated with CAC incidence in asymptomatic populations with CVD, indicating that measuring Lp(a) may be a useful biomarker for diagnosing subclinical atherosclerosis in individuals at higher risk of CAC score.
CRD42022350297.
[Display omitted]
•Elevated Lp(a) level is an independent marker for identifying CVD asymptomatic individuals who are at risk of CAC incidence.•In populations free of CVD symptoms, individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence.•Race could potentially affect the relationship between Lp(a) and CAC.•Both men and women with higher Lp(a) concentrations are at the same risk for increased CAC. |
| doi_str_mv | 10.1016/j.numecd.2023.07.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11073574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939475323002855</els_id><sourcerecordid>2850305946</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-c1dcf96e5d2d8fccde2f373a9e3042f15ee546f21707a79d4b4a54b3d42bd2613</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEotvCGyDkYzkk2LEdbzhQVVX5I1WCA5ytWXtSvErsxXaC9mF4V1ylVHBBnEby_OYbz8xXVS8YbRhl3et94-cJjW1a2vKGqoYy-ajaMNnTmqu2f1xtaM_7WijJT6rTlPaUckW5eFqdcCU7pXq2qX5-jmidyW5BssA4IwkDGd0hHGLI6Pw5vCLOExNi8BCPBGLGEgyMxg3OQHbBE5iCvyWQjtMhh6m8mQJE68ICycwjRGJdQkhI0rzbo8npDbkk6ZgyrnTExeEPAt6SCTPU4GE8JpeeVU8GGBM-v49n1dd311-uPtQ3n95_vLq8qY3oVa4Ns2boO5S2tdvBGIvtwBWHHjkV7cAkohTd0DJFFajeip0AKXbcinZn247xs-pi1T3MuwmtQZ8jjPoQ3VSG1gGc_jvj3Td9GxbNGFVcKlEUzu8VYvg-Y8p6csngOILHMCfdbreqox2V9D_QAlHZi66gYkVNDClFHB6-xKi-c4He69UF-s4FmipdXFDKXv45zkPR77MX4O0KYFlqWX3UyTj0plghlvNoG9y_O_wCnOHLGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2850305946</pqid></control><display><type>article</type><title>Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vazirian, Fatemeh ; Sadeghi, Masoumeh ; Kelesidis, Theodoros ; Budoff, Matthew J. ; Zandi, Zahra ; Samadi, Sara ; Mohammadpour, Amir Hooshang</creator><creatorcontrib>Vazirian, Fatemeh ; Sadeghi, Masoumeh ; Kelesidis, Theodoros ; Budoff, Matthew J. ; Zandi, Zahra ; Samadi, Sara ; Mohammadpour, Amir Hooshang</creatorcontrib><description>Studies have indicated inconsistent results regarding the association between plasma levels of Lipoprotein(a) [Lp(a)] and coronary artery calcification (CAC). We performed a systematic review and meta-analysis to investigate the association between elevated levels of Lp(a) and risk of CAC in populations free of cardiovascular disease (CVD) symptoms.
PubMed, Web of Science, Embase, and Scopus were searched up to July 2022 and the methodological quality was assessed using Newcastle–Ottawa Scale (NOS) scale. Random-effects meta-analysis was used to estimate pooled odds ratio (OR) and 95% confidence interval. Out of 298 studies, data from 8 cross-sectional (n = 18,668) and 4 cohort (n = 15,355) studies were used in meta-analysis. Cohort studies demonstrated a positive significant association between Lp(a) and CAC, so that individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence compared to those with lower Lp(a) concentrations in asymptomatic CVD subjects (OR, 1.58; 95% CI, 1.38–1.80; l2, 0.0%; P, 0.483); Subgroup analysis showed that a cut-off level for Lp(a) measurement could not statistically affect the association, but race significantly affected the relationship between Lp(a) and CAC (OR,1.60; 95% CI, 1.41–1.81). Analyses also revealed that both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.
Blood Lp(a) level was significantly associated with CAC incidence in asymptomatic populations with CVD, indicating that measuring Lp(a) may be a useful biomarker for diagnosing subclinical atherosclerosis in individuals at higher risk of CAC score.
CRD42022350297.
[Display omitted]
•Elevated Lp(a) level is an independent marker for identifying CVD asymptomatic individuals who are at risk of CAC incidence.•In populations free of CVD symptoms, individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence.•Race could potentially affect the relationship between Lp(a) and CAC.•Both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.</description><identifier>ISSN: 0939-4753</identifier><identifier>EISSN: 1590-3729</identifier><identifier>DOI: 10.1016/j.numecd.2023.07.015</identifier><identifier>PMID: 37567791</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Aged ; Asymptomatic Diseases ; atherosclerosis ; biomarkers ; Biomarkers - blood ; blood ; CAC ; calcification ; cardiovascular disease ; confidence interval ; Coronary Artery Disease - blood ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - diagnostic imaging ; Coronary Artery Disease - epidemiology ; coronary vessels ; Female ; Humans ; Incidence ; lipoprotein(a) ; Lipoprotein(a) - blood ; lipoproteins ; Male ; meta-analysis ; metabolism ; Middle Aged ; nutrition ; odds ratio ; Predictive Value of Tests ; Prognosis ; risk ; Risk Assessment ; Risk Factors ; systematic review ; Up-Regulation ; Vascular Calcification - blood ; Vascular Calcification - diagnosis ; Vascular Calcification - diagnostic imaging ; Vascular Calcification - epidemiology</subject><ispartof>Nutrition, metabolism, and cardiovascular diseases, 2023-11, Vol.33 (11), p.2055-2066</ispartof><rights>2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University</rights><rights>Copyright © 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-c1dcf96e5d2d8fccde2f373a9e3042f15ee546f21707a79d4b4a54b3d42bd2613</citedby><cites>FETCH-LOGICAL-c497t-c1dcf96e5d2d8fccde2f373a9e3042f15ee546f21707a79d4b4a54b3d42bd2613</cites><orcidid>0000-0002-0132-4491 ; 0000-0002-8463-3811 ; 0000-0002-1357-7605</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.numecd.2023.07.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37567791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vazirian, Fatemeh</creatorcontrib><creatorcontrib>Sadeghi, Masoumeh</creatorcontrib><creatorcontrib>Kelesidis, Theodoros</creatorcontrib><creatorcontrib>Budoff, Matthew J.</creatorcontrib><creatorcontrib>Zandi, Zahra</creatorcontrib><creatorcontrib>Samadi, Sara</creatorcontrib><creatorcontrib>Mohammadpour, Amir Hooshang</creatorcontrib><title>Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis</title><title>Nutrition, metabolism, and cardiovascular diseases</title><addtitle>Nutr Metab Cardiovasc Dis</addtitle><description>Studies have indicated inconsistent results regarding the association between plasma levels of Lipoprotein(a) [Lp(a)] and coronary artery calcification (CAC). We performed a systematic review and meta-analysis to investigate the association between elevated levels of Lp(a) and risk of CAC in populations free of cardiovascular disease (CVD) symptoms.
PubMed, Web of Science, Embase, and Scopus were searched up to July 2022 and the methodological quality was assessed using Newcastle–Ottawa Scale (NOS) scale. Random-effects meta-analysis was used to estimate pooled odds ratio (OR) and 95% confidence interval. Out of 298 studies, data from 8 cross-sectional (n = 18,668) and 4 cohort (n = 15,355) studies were used in meta-analysis. Cohort studies demonstrated a positive significant association between Lp(a) and CAC, so that individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence compared to those with lower Lp(a) concentrations in asymptomatic CVD subjects (OR, 1.58; 95% CI, 1.38–1.80; l2, 0.0%; P, 0.483); Subgroup analysis showed that a cut-off level for Lp(a) measurement could not statistically affect the association, but race significantly affected the relationship between Lp(a) and CAC (OR,1.60; 95% CI, 1.41–1.81). Analyses also revealed that both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.
Blood Lp(a) level was significantly associated with CAC incidence in asymptomatic populations with CVD, indicating that measuring Lp(a) may be a useful biomarker for diagnosing subclinical atherosclerosis in individuals at higher risk of CAC score.
CRD42022350297.
[Display omitted]
•Elevated Lp(a) level is an independent marker for identifying CVD asymptomatic individuals who are at risk of CAC incidence.•In populations free of CVD symptoms, individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence.•Race could potentially affect the relationship between Lp(a) and CAC.•Both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.</description><subject>Adult</subject><subject>Aged</subject><subject>Asymptomatic Diseases</subject><subject>atherosclerosis</subject><subject>biomarkers</subject><subject>Biomarkers - blood</subject><subject>blood</subject><subject>CAC</subject><subject>calcification</subject><subject>cardiovascular disease</subject><subject>confidence interval</subject><subject>Coronary Artery Disease - blood</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - diagnostic imaging</subject><subject>Coronary Artery Disease - epidemiology</subject><subject>coronary vessels</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>lipoprotein(a)</subject><subject>Lipoprotein(a) - blood</subject><subject>lipoproteins</subject><subject>Male</subject><subject>meta-analysis</subject><subject>metabolism</subject><subject>Middle Aged</subject><subject>nutrition</subject><subject>odds ratio</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>risk</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>systematic review</subject><subject>Up-Regulation</subject><subject>Vascular Calcification - blood</subject><subject>Vascular Calcification - diagnosis</subject><subject>Vascular Calcification - diagnostic imaging</subject><subject>Vascular Calcification - epidemiology</subject><issn>0939-4753</issn><issn>1590-3729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks9u1DAQxiMEotvCGyDkYzkk2LEdbzhQVVX5I1WCA5ytWXtSvErsxXaC9mF4V1ylVHBBnEby_OYbz8xXVS8YbRhl3et94-cJjW1a2vKGqoYy-ajaMNnTmqu2f1xtaM_7WijJT6rTlPaUckW5eFqdcCU7pXq2qX5-jmidyW5BssA4IwkDGd0hHGLI6Pw5vCLOExNi8BCPBGLGEgyMxg3OQHbBE5iCvyWQjtMhh6m8mQJE68ICycwjRGJdQkhI0rzbo8npDbkk6ZgyrnTExeEPAt6SCTPU4GE8JpeeVU8GGBM-v49n1dd311-uPtQ3n95_vLq8qY3oVa4Ns2boO5S2tdvBGIvtwBWHHjkV7cAkohTd0DJFFajeip0AKXbcinZn247xs-pi1T3MuwmtQZ8jjPoQ3VSG1gGc_jvj3Td9GxbNGFVcKlEUzu8VYvg-Y8p6csngOILHMCfdbreqox2V9D_QAlHZi66gYkVNDClFHB6-xKi-c4He69UF-s4FmipdXFDKXv45zkPR77MX4O0KYFlqWX3UyTj0plghlvNoG9y_O_wCnOHLGA</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Vazirian, Fatemeh</creator><creator>Sadeghi, Masoumeh</creator><creator>Kelesidis, Theodoros</creator><creator>Budoff, Matthew J.</creator><creator>Zandi, Zahra</creator><creator>Samadi, Sara</creator><creator>Mohammadpour, Amir Hooshang</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0132-4491</orcidid><orcidid>https://orcid.org/0000-0002-8463-3811</orcidid><orcidid>https://orcid.org/0000-0002-1357-7605</orcidid></search><sort><creationdate>20231101</creationdate><title>Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis</title><author>Vazirian, Fatemeh ; Sadeghi, Masoumeh ; Kelesidis, Theodoros ; Budoff, Matthew J. ; Zandi, Zahra ; Samadi, Sara ; Mohammadpour, Amir Hooshang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-c1dcf96e5d2d8fccde2f373a9e3042f15ee546f21707a79d4b4a54b3d42bd2613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Asymptomatic Diseases</topic><topic>atherosclerosis</topic><topic>biomarkers</topic><topic>Biomarkers - blood</topic><topic>blood</topic><topic>CAC</topic><topic>calcification</topic><topic>cardiovascular disease</topic><topic>confidence interval</topic><topic>Coronary Artery Disease - blood</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - diagnostic imaging</topic><topic>Coronary Artery Disease - epidemiology</topic><topic>coronary vessels</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>lipoprotein(a)</topic><topic>Lipoprotein(a) - blood</topic><topic>lipoproteins</topic><topic>Male</topic><topic>meta-analysis</topic><topic>metabolism</topic><topic>Middle Aged</topic><topic>nutrition</topic><topic>odds ratio</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>risk</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>systematic review</topic><topic>Up-Regulation</topic><topic>Vascular Calcification - blood</topic><topic>Vascular Calcification - diagnosis</topic><topic>Vascular Calcification - diagnostic imaging</topic><topic>Vascular Calcification - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vazirian, Fatemeh</creatorcontrib><creatorcontrib>Sadeghi, Masoumeh</creatorcontrib><creatorcontrib>Kelesidis, Theodoros</creatorcontrib><creatorcontrib>Budoff, Matthew J.</creatorcontrib><creatorcontrib>Zandi, Zahra</creatorcontrib><creatorcontrib>Samadi, Sara</creatorcontrib><creatorcontrib>Mohammadpour, Amir Hooshang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrition, metabolism, and cardiovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vazirian, Fatemeh</au><au>Sadeghi, Masoumeh</au><au>Kelesidis, Theodoros</au><au>Budoff, Matthew J.</au><au>Zandi, Zahra</au><au>Samadi, Sara</au><au>Mohammadpour, Amir Hooshang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis</atitle><jtitle>Nutrition, metabolism, and cardiovascular diseases</jtitle><addtitle>Nutr Metab Cardiovasc Dis</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>33</volume><issue>11</issue><spage>2055</spage><epage>2066</epage><pages>2055-2066</pages><issn>0939-4753</issn><eissn>1590-3729</eissn><abstract>Studies have indicated inconsistent results regarding the association between plasma levels of Lipoprotein(a) [Lp(a)] and coronary artery calcification (CAC). We performed a systematic review and meta-analysis to investigate the association between elevated levels of Lp(a) and risk of CAC in populations free of cardiovascular disease (CVD) symptoms.
PubMed, Web of Science, Embase, and Scopus were searched up to July 2022 and the methodological quality was assessed using Newcastle–Ottawa Scale (NOS) scale. Random-effects meta-analysis was used to estimate pooled odds ratio (OR) and 95% confidence interval. Out of 298 studies, data from 8 cross-sectional (n = 18,668) and 4 cohort (n = 15,355) studies were used in meta-analysis. Cohort studies demonstrated a positive significant association between Lp(a) and CAC, so that individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence compared to those with lower Lp(a) concentrations in asymptomatic CVD subjects (OR, 1.58; 95% CI, 1.38–1.80; l2, 0.0%; P, 0.483); Subgroup analysis showed that a cut-off level for Lp(a) measurement could not statistically affect the association, but race significantly affected the relationship between Lp(a) and CAC (OR,1.60; 95% CI, 1.41–1.81). Analyses also revealed that both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.
Blood Lp(a) level was significantly associated with CAC incidence in asymptomatic populations with CVD, indicating that measuring Lp(a) may be a useful biomarker for diagnosing subclinical atherosclerosis in individuals at higher risk of CAC score.
CRD42022350297.
[Display omitted]
•Elevated Lp(a) level is an independent marker for identifying CVD asymptomatic individuals who are at risk of CAC incidence.•In populations free of CVD symptoms, individuals with Lp(a)≥30–50 exposed to about 60% risk of CAC incidence.•Race could potentially affect the relationship between Lp(a) and CAC.•Both men and women with higher Lp(a) concentrations are at the same risk for increased CAC.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37567791</pmid><doi>10.1016/j.numecd.2023.07.015</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0132-4491</orcidid><orcidid>https://orcid.org/0000-0002-8463-3811</orcidid><orcidid>https://orcid.org/0000-0002-1357-7605</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0939-4753 |
| ispartof | Nutrition, metabolism, and cardiovascular diseases, 2023-11, Vol.33 (11), p.2055-2066 |
| issn | 0939-4753 1590-3729 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11073574 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Asymptomatic Diseases atherosclerosis biomarkers Biomarkers - blood blood CAC calcification cardiovascular disease confidence interval Coronary Artery Disease - blood Coronary Artery Disease - diagnosis Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - epidemiology coronary vessels Female Humans Incidence lipoprotein(a) Lipoprotein(a) - blood lipoproteins Male meta-analysis metabolism Middle Aged nutrition odds ratio Predictive Value of Tests Prognosis risk Risk Assessment Risk Factors systematic review Up-Regulation Vascular Calcification - blood Vascular Calcification - diagnosis Vascular Calcification - diagnostic imaging Vascular Calcification - epidemiology |
| title | Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A33%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20value%20of%20lipoprotein(a)%20in%20coronary%20artery%20calcification%20among%20asymptomatic%20cardiovascular%20disease%20subjects:%20A%20systematic%20review%20and%20meta-analysis&rft.jtitle=Nutrition,%20metabolism,%20and%20cardiovascular%20diseases&rft.au=Vazirian,%20Fatemeh&rft.date=2023-11-01&rft.volume=33&rft.issue=11&rft.spage=2055&rft.epage=2066&rft.pages=2055-2066&rft.issn=0939-4753&rft.eissn=1590-3729&rft_id=info:doi/10.1016/j.numecd.2023.07.015&rft_dat=%3Cproquest_pubme%3E2850305946%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2850305946&rft_id=info:pmid/37567791&rft_els_id=S0939475323002855&rfr_iscdi=true |